Lerner Lorena Raquel
- SEC CIK
- 0002081359
Latest role at each company
- KROS Keros Therapeutics, Inc.Chief Scientific Officeras of Aug 20, 2026
Trades
Every Form 4 that lists Lerner Lorena Raquel as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| KROSKeros Therapeutics, Inc. | Aug 20, 20264:10 PM ET | Aug 18, 2026 | Lerner Lorena RaquelChief Scientific Officer | SSaleCommon Stock | −3.57K | $10.29 | −$36.71K | 27.56K | −11.5% | SEC |
| KROSKeros Therapeutics, Inc. | Feb 20, 2026 | Feb 18, 2026 | Lerner Lorena RaquelChief Science Officer | SSaleCommon Stock | −3.87K | $16.35 | −$63.32K | 31.13K | −11.1% | SEC |